Trial Profile

EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 26 Mar 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Collagenase clostridium histolyticum (Primary)
Indications Cellulite
Focus Therapeutic Use
Sponsors Endo Pharmaceuticals

Most Recent Events

19 Mar 2019 According to an Endo International media release, Dr. Neil Sadick is a lead investigator.
19 Mar 2019 According to an Endo International media release, the data from this trial published in Dermatologic Surgery, the official journal of the American Society for Dermatologic Surgery 2019.
19 Mar 2019 Results published in the Endo International Media Release

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com